OMRON Selects IPfolio from Clarivate
IP solution maximizes operational efficiency for leading automation company LONDON, May 9, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today thatOMRON has selected IPfolio™, an intellectual property management software from ...
Clarivate Introduces Epidemiology Intelligence™ for Precision Patient Population Analysis
Empowering biopharma with unified epidemiology, incidence and prevalence data alongside claims-based population insights, for precise market sizing and patient population analysis LONDON, May 7, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intellig...
Clarivate Enhances Cortellis CMC Intelligence with Post-Approval Module to Accelerate Regulatory Success
Enhancements enable pharma, biotech and generics companies to streamline regulatory tracking and optimize life cycle management for small molecules and biologics LONDON, May 2, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announ...
BioWorld by Clarivate Explores the Future of CAR T Therapy in Mainland China in Special Report
Three-part report investigates rapid pipeline growth, partnerships, clinical trials, and patient access challenges in cancer treatment LONDON, April 30, 2024 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, explores the ...
Clarivate joins United Nations SDG Publishers Compact
LONDON, April 24, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announces it has signed theUnited Nations Sustainable Development Goals (UN SDGs) Publishers Compact. Signatories of the compact pledge to develop sustainable practice...
Clarivate Acquires Global QMS, Inc., Expanding Life Sciences & Healthcare Segment into New Markets
Acquisition supports critical client workflow and reporting needs with proprietary SaaS platform, automating regulatory report authoring and compliance across manufacturing operations, supply chain and quality management LONDON, April 23, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading ...
Clarivate Launches LatAm Market Tracking Solution in Partnership with Global Health Intelligence Enabling Real-Time Tracking of Medical Device Markets
New solution offers comprehensive tracking and analysis of market share and size inBrazil, Colombia, Argentina, Chile, Peru and Ecuador LONDON, April 17, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released itsLatAm market ...
Clarivate Acquires AI Start Up to Accelerate Strategy and Business Development Success for Life Sciences & Healthcare Clients
Acquisition of MotionHall reinforces strategy to lead market-specific solutions, including workflows and expert services fuelled by industry vertical AI LONDON, March 21, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, has announced an agr...
Clarivate Reveals Top 100 Global Innovators 2024
New report introduces rankings for the first time; Samsung Electronics leads the list LONDON, March 5, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today revealed its 2024 list of Top 100 Global Innovators™ – organizations leading the...
Clarivate and Exor Sign Agreement Under Which Suzanne Heywood Will Be Nominated to Stand for Election to the Company's Board of Directors
Exor becomes a long-term investor in Clarivate, endorsing the strategic direction set out by the Company's Management and Board, andannounces it now has a 10.1% shareholding in the Company and can increase its participation up to 17.5% LONDON and AMSTERDAM, March 4, 2024 /PRNewswire/ -- Clarivat...
Clarivate Recognized in the WTR 1000 2024 for Trademark Business
Highly recommended in trademark management, searching and watching, renewals and recordals LONDON, Feb. 23, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, has been recognized in theWTR 1000 2024 by the World Trademark Review. This guide...
Clarivate Launches New Center for Intellectual Property and Innovation Research
Bringing together expertise, operational practice knowledge and powerful data models to improve innovation and IP decision-making LONDON, Feb. 20, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today launched the Clarivate Center for IP...
Clarivate Partners with the Financial Times to Power its Business School Rankings
LONDON, Feb. 12, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global provider of transformative intelligence, has partnered with theFinancial Times (FT) for the sixth consecutive year to provide it with trusted high-quality data for three of its business school rankings, including the Global...
Clarivate Launches Web of Science Grants Index to Help Researchers Optimize Funding Strategies
New solution integrates curated data from Pivot-RP to the Web of Science and offers an expanded view of the funding landscape LONDON, Jan. 29, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their ...
Clarivate Identifies Thirteen Potential Blockbuster Drugs and Gamechangers in Annual Drugs to Watch Report
Therapeutic advancements for sickle cell disease, RSV, breast cancer, Crohn's and other ailments poised to advance patient health despite urgent challenges facing life science companies LONDON, Jan. 8, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organ...
Clarivate Reveals Stronger Outlook for Pulsed-field Ablation Market and Potential for Device to Revolutionize Treatment Paradigm
MedTech Insights report series analyzes the impact of recent breakthroughs in pulsed-field ablation, signaling its promising future in the electrophysiology mapping and ablation device market LONDON, Dec. 19, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people an...
Clarivate Expands Partnership with VeriSIM Life to Accelerate and De-risk Research and Drug Development
New AI-enabled, integrated workflow provides pharma and biotech companies with comprehensive R&D insights to help minimize late-stage failures during clinical trials LONDON, Dec. 5, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intellig...
Clarivate Reveals World's Influential Researchers in Highly Cited Researchers 2023 List
Concentration of top talent with 10 countries/regions representing over 80% of list LONDON, Nov. 15, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today revealed its 2023 list ofHigh...
Clarivate Report Reveals China Challenging U.S. Research Dominance, Signaling Future Research Ambitions
Institute for Scientific Information shows China matching research productivity with excellence, diversifying its research economy and expanding its collaboration network LONDON, Oct. 31, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to in...
Clarivate Partners with EveryLibrary to Support and Nurture Libraries in the U.S.
Leveraging the strengths of the two organizations to aid libraries through dedicated resources and advocacy LONDON, Oct. 26, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today annou...
